Oppenheimer Maintains Outperform on Bioceres Crop Solutions, Lowers Price Target to $7
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Oppenheimer analyst Kristen Owen maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Outperform and lowers the price target from $8 to $7.
Oppenheimer analyst Kristen Owen maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Outperform and lowers the price target from $8 to $7.